The Clorox Company Q3 2026 Financial Report: Key Insights for Investors

Executive Summary

The Clorox Company (NYSE: CLX) has released its quarterly report for the period ended March 31, 2026. This report contains several important developments that shareholders and potential investors should carefully consider. Clorox, a leading consumer products company, has disclosed its financial performance, balance sheet position, and key operational metrics for the third quarter of fiscal year 2026.

Key Financial Highlights

• Net Earnings: Clorox reported net earnings of \$191 million for the three months ended March 31, 2026, and \$434 million for the nine months ended March 31, 2026. This reflects a stable profitability trend, with net earnings per share (EPS) for the quarter at \$1.51 (basic) and \$1.50 (diluted), and \$3.48 (basic) and \$3.47 (diluted) for the nine months.
• Revenue and Gross Profit: Gross profit for the quarter was \$744 million, with \$2,040 million for the nine months. This indicates continued strength in core operations.
• Advertising and R&D Spend: Clorox invested \$207 million in advertising for the quarter and \$533 million year-to-date. Research and development expense was \$27 million for the quarter and \$84 million for the nine months, showing ongoing commitment to brand building and innovation.
• Comprehensive Income: Comprehensive income net of tax was \$429 million for the nine months, after accounting for other comprehensive items such as foreign currency translation and derivative gains/losses.
• Balance Sheet Position:
  • Total assets stood at \$5.56 billion as of March 31, 2026.
  • Total liabilities and stockholders’ equity amounted to \$6.44 billion.
  • Stockholders’ equity decreased to \$92 million, a notable drop from \$482 million the previous year, indicating possible dividend payments, share repurchases, or other equity changes that investors should scrutinize.
  • Cash and cash equivalents remain strong, supporting liquidity.
• Shares Outstanding: As of April 16, 2026, Clorox had 120,921,351 shares outstanding.

Price-Sensitive Items & Potential Share Price Impact

• Stockholders’ Equity Decline: The sharp decrease in stockholders’ equity from \$482 million to \$92 million is a significant concern. Investors should investigate whether this was due to substantial share repurchases, dividend payments, or other capital actions, as it may affect the company’s financial stability and valuation multiples.
• Commitments and Contingencies: The report notes commitments and contingencies, but does not specify amounts. Any undisclosed legal, regulatory, or operational risks could be material and affect future earnings and share price.
• Debt Position: Clorox’s commercial paper outstanding was \$1.59 billion, with only \$4 million remaining at the end of the quarter. This suggests active management of short-term debt, but investors should monitor future refinancing risks and interest expense trends.
• Dividend Policy & Share Repurchases: The report references treasury stock and retained earnings movements, potentially signaling dividend payments or buybacks. These capital return policies can impact share price performance and investor sentiment.

Operational and Strategic Updates

• Continued Investment in Brands: High advertising and R&D spend reinforces Clorox’s focus on maintaining market share and launching new products. This is a positive indicator for long-term growth, though it may pressure near-term margins.
• Market Risk Disclosures: Items regarding derivative instruments, foreign exchange, and interest rate risk point to active risk management. Investors should review these disclosures for potential future volatility in earnings.
• No Preferred Stock Issuance: Clorox maintains a conservative capital structure with no preferred stock outstanding.
• Compliance and Reporting: Clorox has fully complied with SEC reporting requirements and submitted all interactive data files, demonstrating strong governance.

Shareholder Information

• Common Stock: Clorox’s common stock is listed on the NYSE under the ticker “CLX”.
• Shares Outstanding: 120,921,351 shares as of April 16, 2026.
• Authorized Shares: 750 million shares authorized, with 130,741,461 issued.

Potential Risks and Areas to Monitor

• Equity Decline: The drop in stockholders’ equity warrants further investigation. Investors should monitor for any upcoming announcements regarding capital structure changes, dividends, or buybacks.
• Debt Servicing: Clorox’s use of commercial paper and interest expense trends could affect cash flows and future profitability.
• Contingencies: Any material events related to commitments and contingencies could impact financial results and share value.

Conclusion

Clorox’s Q3 2026 report shows steady profitability and ongoing investment in growth, but the significant reduction in stockholders’ equity is a potential red flag for investors. The company’s liquidity position appears strong, but active debt management and undisclosed contingencies could pose risks. Shareholders should pay close attention to future disclosures regarding equity, capital returns, and any material commitments that could affect valuation and share price performance.

Disclaimer: This article is intended for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any securities. Investors should conduct their own research and consult with professional advisors before making investment decisions.

View CLOROX CO /DE/ Historical chart here